APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Montagne, Axel, Nation, Daniel A., Sagare, Abhay P., Barisano, Giuseppe, Sweeney, Melanie D., Chakhoyan, Ararat, Pachicano, Maricarmen, Joe, Elizabeth, Nelson, Amy R., D’Orazio, Lina M., Buennagel, David P., Harrington, Michael G., Benzinger, Tammie L. S., Fagan, Anne M., Ringman, John M., Schneider, Lon S., Morris, John C., Reiman, Eric M., Caselli, Richard J., Chui, Helena C., TCW, Julia, Chen, Yining, Pa, Judy, Conti, Peter S., Law, Meng, Toga, Arthur W., Zlokovic, Berislav V.
Published in Nature (London) (01.05.2020)
Published in Nature (London) (01.05.2020)
Get full text
Journal Article
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, Daniel A., Sweeney, Melanie D., Montagne, Axel, Sagare, Abhay P., D’Orazio, Lina M., Pachicano, Maricarmen, Sepehrband, Farshid, Nelson, Amy R., Buennagel, David P., Harrington, Michael G., Benzinger, Tammie L. S., Fagan, Anne M., Ringman, John M., Schneider, Lon S., Morris, John C., Chui, Helena C., Law, Meng, Toga, Arthur W., Zlokovic, Berislav V.
Published in Nature medicine (01.02.2019)
Published in Nature medicine (01.02.2019)
Get full text
Journal Article
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Dubois, Bruno, Hampel, Harald, Feldman, Howard H, Scheltens, Philip, Aisen, Paul, Andrieu, Sandrine, Bakardjian, Hovagim, Benali, Habib, Bertram, Lars, Blennow, Kaj, Broich, Karl, Cavedo, Enrica, Crutch, Sebastian, Dartigues, Jean-François, Duyckaerts, Charles, Epelbaum, Stéphane, Frisoni, Giovanni B, Gauthier, Serge, Genthon, Remy, Gouw, Alida A, Habert, Marie-Odile, Holtzman, David M, Kivipelto, Miia, Lista, Simone, Molinuevo, José-Luis, O'Bryant, Sid E, Rabinovici, Gil D, Rowe, Christopher, Salloway, Stephen, Schneider, Lon S, Sperling, Reisa, Teichmann, Marc, Carrillo, Maria C, Cummings, Jeffrey, Jack, Cliff R
Published in Alzheimer's & dementia (01.03.2016)
Published in Alzheimer's & dementia (01.03.2016)
Get full text
Journal Article
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
Colom-Cadena, Martí, Spires-Jones, Tara, Zetterberg, Henrik, Blennow, Kaj, Caggiano, Anthony, DeKosky, Steven T, Fillit, Howard, Harrison, John E, Schneider, Lon S, Scheltens, Phillip, de Haan, Willem, Grundman, Michael, van Dyck, Christopher H, Izzo, Nicholas J, Catalano, Susan M
Published in Alzheimer's research & therapy (02.03.2020)
Published in Alzheimer's research & therapy (02.03.2020)
Get full text
Journal Article
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Gauthier, Serge, Prof, Feldman, Howard H, Prof, Schneider, Lon S, Prof, Wilcock, Gordon K, Prof, Frisoni, Giovanni B, Prof, Hardlund, Jiri H, MD, Moebius, Hans J, MD, Bentham, Peter, MBChB, Kook, Karin A, PhD, Wischik, Damon J, PhD, Schelter, Bjoern O, Prof, Davis, Charles S, PhD, Staff, Roger T, PhD, Bracoud, Luc, MSc, Shamsi, Kohkan, MD, Storey, John M D, Prof, Harrington, Charles R, PhD, Wischik, Claude M, Prof
Published in The Lancet (British edition) (10.12.2016)
Published in The Lancet (British edition) (10.12.2016)
Get full text
Journal Article
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Bateman, Randall J, Benzinger, Tammie L, Berry, Scott, Clifford, David B, Duggan, Cynthia, Fagan, Anne M, Fanning, Kathleen, Farlow, Martin R, Hassenstab, Jason, McDade, Eric M, Mills, Susan, Paumier, Katrina, Quintana, Melanie, Salloway, Stephen P, Santacruz, Anna, Schneider, Lon S, Wang, Guoqiao, Xiong, Chengjie
Published in Alzheimer's & dementia (01.01.2017)
Published in Alzheimer's & dementia (01.01.2017)
Get full text
Journal Article
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists
Yassine, Hussein N., Solomon, Victoria, Thakral, Angad, Sheikh‐Bahaei, Nasim, Chui, Helena C., Braskie, Meredith N., Schneider, Lon. S., Talbot, Konrad
Published in Alzheimer's & dementia (01.03.2022)
Published in Alzheimer's & dementia (01.03.2022)
Get full text
Journal Article
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials
Goldberg, Terry E, Harvey, Philip D, Wesnes, Keith A, Snyder, Peter J, Schneider, Lon S
Published in Alzheimer's & dementia : diagnosis, assessment & disease monitoring (01.03.2015)
Published in Alzheimer's & dementia : diagnosis, assessment & disease monitoring (01.03.2015)
Get full text
Journal Article
Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis
Nelson, J. Craig, Delucchi, Kevin L., Schneider, Lon S.
Published in The American journal of psychiatry (01.06.2013)
Published in The American journal of psychiatry (01.06.2013)
Get full text
Journal Article
Accelerating stem cell trials for Alzheimer's disease
Hunsberger, Joshua G, PhD, Rao, Mahendra, Prof, Kurtzberg, Joanne, Prof, Bulte, Jeff W M, Prof, Atala, Anthony, Prof, LaFerla, Frank M, Prof, Greely, Henry T, Prof, Sawa, Akira, Prof, Gandy, Sam, Prof, Schneider, Lon S, Prof, Doraiswamy, P Murali, Prof
Published in Lancet neurology (01.02.2016)
Published in Lancet neurology (01.02.2016)
Get full text
Journal Article
Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy
Wang, Yiwei, Hernandez, Gerson, Mack, Wendy J, Schneider, Lon S, Yin, Fei, Brinton, Roberta D
Published in Menopause (New York, N.Y.) (01.01.2020)
Published in Menopause (New York, N.Y.) (01.01.2020)
Get more information
Journal Article
Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time
Wang, Guoqiao, Kennedy, Richard E, Goldberg, Terry E, Fowler, Mackenzie E, Cutter, Gary R, Schneider, Lon S
Published in PloS one (21.02.2020)
Published in PloS one (21.02.2020)
Get full text
Journal Article
A new roadmap for drug development for Alzheimer's disease
Becker, Robert E., Greig, Nigel H., Giacobini, Ezio, Schneider, Lon S., Ferrucci, Luigi
Published in Nature reviews. Drug discovery (01.02.2014)
Published in Nature reviews. Drug discovery (01.02.2014)
Get full text
Journal Article
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
Arellanes, Isabella C., Choe, Nicholas, Solomon, Victoria, He, Xulei, Kavin, Brian, Martinez, Ashley E., Kono, Naoko, Buennagel, David P., Hazra, Nalini, Kim, Giselle, D'Orazio, Lina M., McCleary, Carol, Sagare, Abhay, Zlokovic, Berislav V., Hodis, Howard N., Mack, Wendy J., Chui, Helena C., Harrington, Michael G., Braskie, Meredith N., Schneider, Lon S., Yassine, Hussein N.
Published in EBioMedicine (01.09.2020)
Published in EBioMedicine (01.09.2020)
Get full text
Journal Article
Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence From the CitAD Study
Leonpacher, Anne K., Peters, Matthew E., Drye, Lea T., Makino, Kelly M., Newell, Jeffery A., Devanand, D.P., Frangakis, Constantine, Munro, Cynthia A., Mintzer, Jacobo E., Pollock, Bruce G., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G., Porsteinsson, Anton P.
Published in The American journal of psychiatry (01.05.2016)
Published in The American journal of psychiatry (01.05.2016)
Get full text
Journal Article